Skip to Main Content (Press Enter)

Logo UNISS
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Professioni
  • Persone
  • Pubblicazioni
  • Strutture
  • Terza Missione
  • Competenze

Logo UNISS

|

UNIFIND

uniss.it
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Professioni
  • Persone
  • Pubblicazioni
  • Strutture
  • Terza Missione
  • Competenze
  1. Pubblicazioni

Metabolic syndrome and body weight in people living with HIV infection: analysis of differences observed in three different cohort studies over a decade

Articolo
Data di Pubblicazione:
2022
Citazione:
Metabolic syndrome and body weight in people living with HIV infection: analysis of differences observed in three different cohort studies over a decade / Taramasso, L; Bonfanti, P; Ricci, E; Maggi, P; Orofino, G; Squillace, N; Menzaghi, B; Madeddu, G; Molteni, C; Vichi, F; Riguccini, E; Saracino, A; Santoro, C; Guastavigna, M; Francisci, D; Di Biagio, A; De Socio, Gv. - In: HIV MEDICINE. - ISSN 1464-2662. - 23:1(2022), pp. 70-79. [10.1111/hiv.13165]
Abstract:
Objectives: The aim of this study was to assess the incidence of being overweight and metabolic syndrome (MS) among people living with HIV (PHIV) in three different cross-sectional studies conducted over three different periods: 2005, 2011 and 2015. Methods: This was a multi-centre, nationwide study. Data were collected in three studies from the CISAI group – SIMOne, HIV-HY and STOPSHIV – and included a total of 3014 PHIV. Logistic regression [odds ratio (OR), 95% confidence interval (CI)] was used to account for age and gender difference among three groups when comparing MS prevalence and being overweight; potential confounders were accounted for by including them in the regression equation. Results: Overall, the mean age was 46.9 ± 10.2 years, and men comprised 73.3% of participants. Comparing 2005, 2011 and 2015, MS was present in 34.5%, 33.0% and 29.3% of PHIV, respectively. Adjusted OR for MS was 0.64 (95% CI: 0.52–0.78) in 2011 and 0.56 (95% CI: 0.46–0.69) in 2015 compared with 2005, while BMI (kg/m2) increased from 23.6 in 2005, 24.5 in 2011 and 24.5 in 2015, with a concomitant increase of being overweight from 29.4% to 39.5% to 39.6% (p < 0.0001). Conclusions: In recent years, PHIV have had a significantly improved metabolic profile compared with previously, despite increasing weight and BMI.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
HIV; antiretroviral therapy; dyslipidaemia; metabolic syndrome; overweight; weight gain; Adult; Body Mass Index; Body Weight; Cohort Studies; Cross-Sectional Studies; Humans; Male; Middle Aged; Prevalence; HIV Infections; Metabolic Syndrome
Elenco autori:
Taramasso, L; Bonfanti, P; Ricci, E; Maggi, P; Orofino, G; Squillace, N; Menzaghi, B; Madeddu, G; Molteni, C; Vichi, F; Riguccini, E; Saracino, A; Santoro, C; Guastavigna, M; Francisci, D; Di Biagio, A; De Socio, Gv
Autori di Ateneo:
MADEDDU Giordano
Link alla scheda completa:
https://iris.uniss.it/handle/11388/278278
Pubblicato in:
HIV MEDICINE
Journal
  • Utilizzo dei cookie

Realizzato con VIVO | Designed by Cineca | 26.5.2.0